Clinical experience with lovastatin

The American Journal of Cardiology

Volumn 65, Issue 12, 1990, Pages 23-26

  Tobert, Jonathan A ^a   Shear, Charles L ^a   Chremos, Athanassios N ^a   Mantell, Geraldine E ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIVER ENZYME; MEVINOLIN;

ADVERSE DRUG REACTION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG THERAPY; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MYOPATHY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; SIDE EFFECT;

CLINICAL TRIALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HUMAN; LOVASTATIN; MULTICENTER STUDIES;

EID: 0025308358     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9149(90)91251-Z     Document Type: Article

References (12)

1. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia
2. Lovastatin: a preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidemia
3. Efficacy and long-term adverse effect pattern of lovastatin
4. Therapeutic response to lovastatin (mevinolin) in nonfamilial hypercholesterolemia
5. A multicenter study of lovastatin (mevinolin) in the treatment of heterozygous familial hypercholesterolemia
6. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia
7. A multicenter comparison of lovastatin and probucol in the therapy of severe primary hypercholesterolemia (abstr)
8. New developments in lipid-lowering therapy: the role of inhibitors of HMG-CoA reductase
9. Long-term experience with HMG-CoA reductase inhibitors in the therapy of hypercholesterolemia
10. Field test reliability of a new lens opacity rating system utilizing slit-lamp examination
11. The physiological disposition of lovastatin